Sales
The Executive Rare Disease Account Liaison (E.RDAL) is a hybrid strategic field role responsible for driving new patients by enabling end-to-end treatment pathways in rare diseases.
Unlike traditional Sales Representatives or Key Account Managers, Executive RDALs drive patient access activation and treatment initiation By bridging across specialties, institutions, and access pathways, E.RDALs convert clinical intent into actual treatment initiation in complex rare disease environments.
Location
Remotely located in designated territory, with regular travel undertaken as required
Core Responsibilities and Deliverables
Patient Pathway Activation & Treatment Initiation
Multidisciplinary Engagement & Referral Network Development
Strategic Account Planning & Insight into Action
Execution Excellence
Performance & General
Key Selection Criteria, Desired Experience & Competencies
The knowledge and skills necessary to perform the duties of this position are typically acquired through the following combination of education, experience and knowledge, or equivalent:
Qualifications
Experience & Skills
Preferred
Executive RDAL Competencies
Clinical Knowledge
Cultivating Impactful Customer Relationships
Business Acumen & Strategic Account Planning
Execution Excellence
The E.RDAL role is currently classified under the Exec Biopharmaceutical Rep job profile. Please note that the position title may be subject to change in the future according to evolving business needs.

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes.
For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads.
🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines
🔗Global Privacy Statement Directory: www.amgen.com/dp
Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.